New life-saving heart attack medication ...( cent. This latest VALIANT trial was lau...),Health

cent. This latest VALIANT trial was launched to compare two unique ways of blocking the angiotensin system in an effort to answer the question: "can we find an even better treatment for heart attack survivors?" said Pfeffer. "The answer is that we found two great methods, one as good as the other."

"We have proven that there is more than one way to manipulate this hormone system to improve the health of a diseased heart," said Pfeffer. "By extending a concept born at Brigham and Women's Hospital more than three decades ago, we have opened up new treatment opportunities for patients and their physicians. As a result of VALIANT, today there exists two proven, effective therapies to preserve life after a heart attack."

Data coordination and analysis for VALIANT were conducted by Duke Clinical Research Institute, Durham, North Carolina, under the direction of Robert M. Califf, MD. This research was funded by Novartis Pharma AG.

'"/>


10-Nov-2003

Page: 1 2 3
Related medicine news :

1. Health report-card fears make doctors forgo potential life-saving heart treatment
2. University of Pennsylvania Health System launches life-saving eICU technology
3. Lack of awareness about stroke hinders use of life-saving drugs, precludes testing of new therapies
4. Improved procurement could more than double availability of life-saving transplant organs
5. High cost of life-saving childrens vaccine may be keeping some doctors from giving it
6. New EC directive threatens life-saving trials
7. Discoverer of life-saving Nomex fire-resistant material earns Lavoisier Achievement award
8. Unergrads invention may deliver life-saving medicine
9. New study in Nature demonstrates protection against cell death during heart attack
10. Uric acid and heart disease
11. Researchers search for first sign of congestive heart failure